References
1. Le C, Bedocs PM. Confluent And Reticulated Papillomatosis. In:StatPearls . StatPearls Publishing; 2021. Accessed December 18,
2021. http://www.ncbi.nlm.nih.gov/books/NBK459130/
2. GOUGEROT H. Papillomatose pigmentee inominee. Bull Soc franc
drrmat et syph . 1927;34:719-721.
3. Davis MDP, Weenig RH, Camilleri MJ. Confluent and reticulate
papillomatosis (Gougerot-Carteaud syndrome): a minocycline-responsive
dermatosis without evidence for yeast in pathogenesis. A study of 39
patients and a proposal of diagnostic criteria: Confluent and reticulate
papillomatosis. British Journal of Dermatology .
2006;154(2):287-293. doi:10.1111/j.1365-2133.2005.06955.x
4. Cannavo S, Guarneri C, Borgia F, Guarneri B. Confluent and
reticulated papillomatosis and acanthosis nigricans in an obese girl:
two distinct pathologies with a common pathogenetic pathway or a unique
entity dependent on insulin resistance? J Eur Acad Dermatol
Venerol . 2006;20(4):478-480. doi:10.1111/j.1468-3083.2006.01476.x
5. Scheinfeld N. Confluent and Reticulated Papillomatosis. Am J
Clin Dermatol . 2006;7(5):305-313. doi:10.2165/00128071-200607050-00004
6. Baalbaki SA. Confluent and Reticulated Papillomatosis: Treatment With
Etretinate. Arch Dermatol . 1993;129(8):961.
doi:10.1001/archderm.1993.01680290033005
7. Solomon BA, Laude TA. Two patients with confluent and reticulated
papillomatosis: Response to oral isotretinoin and 10% lactic acid
lotion. Journal of the American Academy of Dermatology .
1996;35(4):645-646. doi:10.1016/S0190-9622(96)90703-3
8. Özdemir S, Özdemir M, Toy H. Confluent and reticulated papillomatosis
associated with polycystic ovary syndrome treated with a combined
contraceptive containing drospirenone. Journal of the European
Academy of Dermatology and Venereology . 2009;23(3):358-359.
doi:10.1111/j.1468-3083.2008.02847.x
9. Krishnamoorthy M, Nadler E, Vaidya S. Resolution of confluent and
reticulated papillomatosis after bariatric surgery. Clin Obes .
2021;11(1). doi:10.1111/cob.12427